Summit Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Summit Therapeutics Inc. (SMMT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 20.55 million shares as of 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2023-11-07
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 20.55M shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 20.32M shares.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 20.18M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 19.48M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2023-09-30 | 20.55M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 20.32M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 20.18M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 19.48M shares 10-Q · filed 2023-11-07 |
| 2022-09-30 | 19.32M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 17.13M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 13.14M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 13.80M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 12.86M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 5.23M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 5.54M shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 3.67M shares 10-K/A · filed 2022-12-21 |
| 2020-09-30 | 6.15M shares 10-Q · filed 2020-11-16 |
| 2020-06-30 | 4.98M shares 8-K · filed 2020-09-29 |
| 2019-12-31 | 4.64M shares 10-K · filed 2021-03-31 |
| 2019-01-31 | 1.83M shares 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |